Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer More
To identify molecular targets and compounds for cancer therapy
We discover and develop the novel molecular-targeted drugs by using Cancer Cell Informatics.
Telomeres, cell immortality and cancer stemness as therapeutic targets
We promote genome science-driven research for targeted therapy and personalized medicine
We focus the research between clinical samples and imaging the molecular target